Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Immunic Inc

IMUX
Current price
1.2 USD +0.01 USD (+0.84%)
Last closed 1.19 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 48 757 032 USD
Yield for 12 month -10.45 %
Week
Month
Year
IMUX
21.11.2021 - 28.11.2021

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 3 clinical for treatment of multiple sclerosis, including relapsing multiple sclerosis and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York. Address: 1200 Avenue of the Americas, New York, NY, United States, 10036

Analytics

WallStreet Target Price

16.67 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures IMUX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -100 092 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -66.6 %
PEG Ratio
Return On Equity TTM -163.49 %
Wall Street Target Price 16.67 USD
Revenue TTM
Book Value 1.09 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -3.25 USD
Diluted Eps TTM -3.25 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IMUX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IMUX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:40
Payout Ratio
Last Split Date 15.04.2019
Dividend Date 15.04.2019

Stock Valuation IMUX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.3018
Price Book MRQ 0.4258

Financials IMUX

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators IMUX

For 52 weeks

0.95 USD 3.17 USD
50 Day MA 1.22 USD
Shares Short Prior Month 4 340 550
200 Day MA 1.68 USD
Short Ratio 1.98
Shares Short 3 271 554
Short Percent 7.52 %